Last reviewed · How we verify
Placebo Inhalation Powder ACCUHALER/DISKUS — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Inhalation Powder ACCUHALER/DISKUS (Placebo Inhalation Powder ACCUHALER/DISKUS) — GlaxoSmithKline. This is a placebo formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Inhalation Powder ACCUHALER/DISKUS TARGET | Placebo Inhalation Powder ACCUHALER/DISKUS | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Inhalation Powder ACCUHALER/DISKUS CI watch — RSS
- Placebo Inhalation Powder ACCUHALER/DISKUS CI watch — Atom
- Placebo Inhalation Powder ACCUHALER/DISKUS CI watch — JSON
- Placebo Inhalation Powder ACCUHALER/DISKUS alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Inhalation Powder ACCUHALER/DISKUS — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-inhalation-powder-accuhaler-diskus. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab